Digital pathology

BostonGene’s AI-based pathology platform detects and characterizes tissue composition, including tumor, stroma, fibrosis, fat, necrosis and other features. It enables high-throughput analysis, characterizing 100 slides in just 20 minutes.
The clusterization approach significantly improves the efficiency and accuracy of tissue slide analysis, including classification and segmentation, aiding in faster diagnosis and disease subtyping.